期刊文献+

转染mtrⅡ基因后霍奇金病细胞增殖活性改变 被引量:2

Proliferative Activities of Hodgkin's Disease Cells Transfected with mtrⅡ Gene
下载PDF
导出
摘要 目的探讨转染mtrⅡ基因后的霍奇金病细胞增殖活性的改变及其意义。方法将mtrⅡ转染人霍奇金病细胞系,采用免疫组化法检测转染前后ki67基因、增殖细胞核抗原(PCNA)表达情况。结果未转染mtrⅡ基因的ki67阳性率为21.3%,转染mtrⅡ基因后ki67阳性率为36.8%,两者间有显著性差异(P<0.05);未转染mtrⅡ基因的PCNA阳性率为46.1%,转染mtrⅡ基因后PCNA的阳性率为78.6%,两者间有显著性差异(P<0.05)。结论转染mtrⅡ基因后的霍奇金病细胞增殖活性明显增加,提示mtrⅡ基因可能参与了霍奇金病恶性转化的过程。 Objective To investigate the proliferative activities and significance of Hodgkin's disease cells which were transfected with mtr Ⅱ gene. Methods The ki67 and proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease cells transfected with mtr Ⅱ gene were determined with immunohistochemistry. Results The ki67 and PCNA expression in cells transfected with mtr Ⅱ gene was more than that of cells without mtr Ⅱ gene transfected (P〈0.05). Conclusion The proliferative activities of Hodgkin's disease cells transfected with mtr Ⅱ gene increased obviously, which may be related to the progress of Hodgkin's disease.
出处 《中国康复理论与实践》 CSCD 2007年第5期430-431,F0003,共3页 Chinese Journal of Rehabilitation Theory and Practice
基金 福建省自然科学资金资助项目(C0410048)
关键词 mtrⅡ基因 霍奇金病 KI67基因 增殖细胞核抗原(PCNA) mtr Ⅱ gene Hodgkin's disease ki67 gene proliferating cell nuclear antigen (PCNA)
  • 相关文献

参考文献9

  • 1Huang G,Yan Q,Wang Z,et al.Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease[J].lnt J Oncol,2002,21(1):31-36.
  • 2Sons WJ.Ki67-structure,function and new antibodies[J].J Pathol,1992,168(3):161-162.
  • 3Kulldorff M,McShane LM,Schatzkin A,et al.Measuring cell proliferation in the rectal mucosa.comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays[J].J Clin Epidemiol,2000,53(8):875-883.
  • 4萨姆布鲁克,DM拉塞尔.黄培党译.分子克隆实验指南[J].3版.北京:科学出版社,2003:26.
  • 5许福明,马文煜,项秉懿,闫岩,白光春,李元.淋球菌IgA蛋白酶基因中和表位片段的克隆、表达和鉴定[J].第三军医大学学报,2000,22(11):1077-1079. 被引量:5
  • 6Razzaque A,Jahan N,McWeeney D,et al.Localization and DNA sequence analysis of the transforming domain (mtrⅡ) of human cytomegalovirus[J].Proc Natl Acad Sci U S A,1988 ;85(15):5709-5713.
  • 7Thompson J,Doniger J,Rosenthal LJ.A 79 amino acid oncogene is responsible for human cytomegalovirus mtr Ⅱ induced malignant transformation[J].Arch Virol,1994,136(1-2):161-172.
  • 8Zu K,Bihani T,Lin A,et al.Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells[J].Oncogene,2006,25(4):546-554.
  • 9Iwatani Y,Kamigaki T,Suzuki S,et al.Proliferating cell nuclear antigen as a predictor of therapeutic effect of continuous 5-fluorouracil administration in gastric cancer[J].Int J Oncol,1999,14(5):965-970.

二级参考文献1

共引文献4

同被引文献14

  • 1王星,林雨冬,王明元,吴德柱,王煜,杜京丽.霍奇金淋巴瘤转染mtrⅡ基因后增生细胞核抗原表达的意义[J].白血病.淋巴瘤,2008,17(1). 被引量:1
  • 2Huang G, Yah Q, Wang Z, et al. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease. Int J Oncol, 2002, 21: 31-36.
  • 3J.萨姆布鲁克拉塞尔DW.分子克隆实验指南.黄培堂,王嘉玺,朱厚础,等译.3版.北京:科学出版社,2003:26:1731-1732.
  • 4Razzaque A, Jahan N, McWeeney D, et al. Localization and DNA sequence analysis of the transforming domain (mtrⅡ) of human cytomegalovirus. Proc Natl Acad Sci U S A, 1988, 85: 5709-5713.
  • 5Doniger J, Muralidhar S, Rosenthal LJ. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev, 1999, 12: 367-382.
  • 6Jung JE, Kim TK, Lee JS, et al. Survivin inhibits anti-growth effect of p53 activated by aurora B. Biechem Biophys Res Commun, 2005, 336: 1164-1171.
  • 7Wiley J. PCNA-structure,function and new antibodies[J].Journal of Pathology,1992,(03):161-162.
  • 8Huang G,Yan Q,Wang Z. Human eytomegalovirus in neoplastic ceils of Epstein-Barr virus negative Hodgkin disease[J].International Journal of Oncology,2002,(01):31-36.
  • 9Iwatani Y,Kamigaki T,Suzuki S. Proliferating cell nuclear antigen as a predictor of therapeutic effect of continuous 5-fluorouraeil administration in gastric cancer[J].International Journal of Oncology,1999,(05):965-970.
  • 10Kulldorff M,McShane LM,Schatzkin A. Measuring cell proliferation in the rectal mucosa.cbmparing bromodeoxyuridine(BrdU) and proliferating cell nuclear antigen(PCNA) assays[J].Journal of Clinical Epidemiology,2000,(08):875-883.doi:10.1016/S0895-4356(99)00180-8.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部